Both PV and ET humanized scaffolds maintained the JAK2V617F variant allele frequency (VAF), suggesting that a humanized niche is essential for the consistent engraftment of primary CD34+ HSPCs from PV and ET patients (Figures 2C,D, respectively). This evidence concerns the gene CD34 and essential thrombocythemia.